If found to be eligible to take part in this study, participants will receive cyclophosphamide by vein over about 30-60 minutes on Day -2 (2 days before they receive the CD8+ T cells). If the doctor thinks it is needed, they will be given standard drugs to help decrease the risk of side effects. They may ask the study staff for information about how the drug is given and its risks.